Nongenomic signaling pathways triggered by thyroid hormones and their metabolite 3-iodothyronamine on the cardiovascular system

Journal of Cellular Physiology

Volumn 226, Issue 1, 2011, Pages 21-28

  Axelband, F ^a,b   Dias, J ^a,b   Ferrao F M ^a,b   Einicker Lamas, M ^a,b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Instituto Nacional de Ciência e Tecnologia em Biologia Estrutural e Bioimagem   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

3 IODOTHYRONAMINE; ATP SENSITIVE POTASSIUM ION CHANNEL; CELL NUCLEUS RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; LIOTHYRONINE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; POTASSIUM CHANNEL; PROTEIN KINASE C; THYROID HORMONE DERIVATIVE; THYROXINE; UNCLASSIFIED DRUG;

ACTION POTENTIAL; CARDIOVASCULAR SYSTEM; CELL MEMBRANE; CHRONOTROPISM; CYTOPLASM; GENE EXPRESSION; HEART MUSCLE CELL; HEART OUTPUT; HEART VENTRICLE HYPERTROPHY; HOMEOSTASIS; HORMONE ACTION; HYPERTHYROIDISM; HYPOTHYROIDISM; INOTROPISM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMIC VASCULAR RESISTANCE; THYROID GLAND;

ANIMALS; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; GENE EXPRESSION REGULATION; GENOMICS; HUMANS; SIGNAL TRANSDUCTION; THYROID HORMONES; THYRONINES;

EID: 78049270885     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22325     Document Type: Review

References (126)

1. Avkiran M. 1999. Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia. Am J Cardiol 83: 10G-18G.
2. Balkman C, Ojamaa K, Klein I. 1992. Time course of the in vivo effects of thyroid hormone on cardiac gene expression. Endocrinology 130: 2001-2006.
3. Barreto-Chaves ML, Carrillo-Sepúlveda MA, Carneiro-Ramos MS, Gomes DA, Diniz GP. 2010. The crosstalk between thyroid hormones and the Renin-Angiotensin system. Vascul Pharmacol 52: 166-170.
4. Bassettt JH, Harvey CB, Williams GR. 2003. Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol Cell Endocrinol 213: 1-11.
5. Bergh JJ, Lin HY, Lansing L, Mohamed SN, Davis FB, Mousa S, Davis PJ. 2005. Integrin avb3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 146: 2864-2871.
6. Biondi B, Klein I. 2004. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine 24: 1-13.
7. 2+ exchanger expression during postnatal maturation and in adult rabbit ventricular myocardium. Cardiovasc Res 31: E145-E152.
8. Brent GA. 1994. The molecular basis of thyroid hormone action. N Engl J Med 331: 847-853.
9. Cao HJ, Lin HY, Luidens MK, Davis FB, Davis PJ. 2009. Cytoplasm-to-nucleus shuttling of thyroid hormone receptor-beta1 (Trbeta1) is directed from A plasma membrane integrin receptor by thyroid hormone. Endocr Res 34: 31-42.
10. Carrillo-Sepúlveda MA, Ceravolo GS, Fortes ZB, Carvalho MH, Tostes RC, Laurindo FR, Webb RC, Barreto-Chaves ML. 2010. Thyroid hormone stimulates NO production via activation of the PI3K/Akt pathway in vascular myocytes. Cardiovasc Res 85: 560-570.
11. Carvalho-Bianco SD, Kim BW, Zhang JX, Harney JW, Ribeiro RS, Gereben B, Bianco AC, Mende U, Larsen PR. 2004. Chronic cardiac-specific thyrotoxicosis increases myocardial beta-adrenergic responsiveness. Mol Endocrinol 18: 1840-1849.
12. Chakrabarti N, Ray AK. 2000. Rise of intrasynaptosomal Ca2{Thorn} level and activation of nitric oxide synthase in adult rat cerebral cortex pretreated with 3-5-30-L-triiodothyronine. Neuropsychopharmacology 22: 36-41.
13. Chanoine JP, Braverman LE, Farwell AP, Safran M, Alex S, Dubord S, Leonard JL. 1993. The thyroid gland is a major source of circulating T3 in the rat. J Clin Invest 91: 2709-2713.
14. Chiellini G, Apriletti JW, Yoshihara HA, Baxter JD, Ribeiro RC, Scanlan TS. 1998. A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor. Chem Biol 5: 299-306.
15. Chiellini G, Frascarelli S, Ghelardoni S, Carnicelli V, Tobias SC, DeBarber A, Brogioni S, Ronca-Testoni S, Cerbai E, Grandy DK, Scanlan TS, Zucchi R. 2007. Cardiac effects of 3-iodothyronamine: A new aminergic system modulating cardiac function. FASEB J 21: 1597-1608.
16. Cody V, Davis PJ, Davis FB. 2007. Molecular modeling of the thyroid hormone interactions with αVβ3 integrin. Steroids 72: 165-170.
17. Craelius W, Green WL, Harris DR. 1990. Acute effects of thyroid hormone on sodium currents in neonatal myocytes. Biosci Rep 10: 309-315.
18. D'Arezzo S, Incerpi S, Davis FB, Acconcia F, Marino M, Farias RN, Davis PJ. 2004. Rapid nongenomic effects of 3, 5, 3 triiodo-L-thyronine on the intracellular pH of L-6 myoblasts are mediated by intracellular calcium mobilization and kinase pathways. Endocrinology 145: 5694-5703.
19. Danzi S, Ojamaa K, Klein I. 2003. Triiodothyronine-mediated myosin heavy chain gene transcription in the heart. Am J Physiol Heart Circ Physiol 284: H2255-H2262.
20. Davis FB, Mousa SA, O'Connor L, Mohamed S, Lin HY, Cao HJ, Davis PJ. 2004. Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. Circ Res 94: 1500-1506.
21. Davis PJ, Davis FB, Lin HY, Mousa SA, Zhou M, Luidens MK. 2009. Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor. Am J Physiol Endocrinol Metab 297: E1238-E1246.
22. Delp MD, McAllister RM, Laughlin MH. 1995. Exercise training alters aortic vascular reactivity in hypothyroid rats. Am J Physiol 268: H1428-H1435.
23. 2) receptors mediate the increase in TGF-beta1 in thyroid hormone-induced cardiac hypertrophy. Pflugers Arch 454: 75-81.
24. Diniz GP, Carneiro-Ramos MS, Barreto-Chaves ML. 2009. Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway. Basic Res Cardiol 104: 653-667.
25. Doohan MM, Gray DF, Hool LC, Robinson BG, Rasmussen HH. 1997. Thyroid status and regulation of intracellular sodium in rabbit heart. Am J Physiol 272: H1589-H1597.
26. Engler D, Burger AG. 1984. The deiodination of the iodothyronines and of their derivatives in man. Endocr Rev 5: 151-184.
27. 2+ pump isoform 4b by phosphorylation of an inhibitory region downstream of the calmodulin-binding domain. J Biol Chem 271: 32461-32467.
28. Everts ME, Verhoeven FA, Bezstarosti K, Moerings EP, Hennemann G, Visser TJ, Lamers JM. 1996. Uptake of thyroid hormone in neonatal rat cardiac myocytes. Endocrinology 137: 4235-4242.
29. Farach-Carson MC, Davis PJ. 2003. Steroid hormone interactions with target cells: Cross talk between membrane and nuclear pathways. J Pharmacol Exp Ther 307: 839-845.
30. Farwell AP, Dubord-Tomasetti SA, Pietrzykowski AZ, Leonard JL. 2006. Dynamic nongenomic actions of thyroid hormone in the developing rat brain. Endocrinology 147: 2567-2574.
31. Felzen B, Sweed Y, Binah O. 1989. Electrophysiological effects of thyroid hormones in guinea-pig ventricular muscle: Time course and relationships to blood levels. J Mol Cell Cardiol 21: 1151-1161.
32. + current in rat ventricle. J Physiol 500: 51-64.
33. Forini F, Nicolini G, Balzan S, Ratto GM, Murzi B, Vanini V, Iervasi G. 2004. Amiodarone inhibits the 3, 5, 3'-triiodothyronine-dependent increase of sodium/potassium adenosine triphosphatase activity and concentration in human atrialmyocardial tissue. Thyroid 14: 493-499.
34. Frascarelli S, Ghelardoni S, Chiellini G, Vargiu R, Ronca-Testoni S, Scanlan TS, Grandy DK, Zucchi R. 2008. Cardiac effects of trace amines: Pharmacological characterization of trace amine-associated receptors. Eur J Pharmacol 587: 231-236.
35. Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, Visser TJ. 2003. Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 278: 40128-40135.
36. Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K. 2000. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101: 660-667.
37. Fukuyama K, Ichiki T, Takeda K, Tokunou T, Iino N, Masuda S, Ishibashi M, Egashira K, Shimokawa H, Hirano K, Kanaide H, Takeshita A. 2003. Downregulation of vascular angiotensin II type 1 receptor by thyroid hormone. Hypertension 41: 598-603.
38. Furuya F, Lu C, Guigon CJ, Cheng SY. 2009. Nongenomic activation of phosphatidylinositol 3-kinase signaling by thyroid hormone receptors. Steroids 74: 628-634.
39. + exchange in MDCK cells by aldosterone involves MAP-kinases ERK 1/2. Pflügers Arch Eur J Physiol 441: 781-786.
40. Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, Simonides WS, Zeöld A, Bianco AC. 2008. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev 29: 898-938.
41. Ghelardoni S, Suffredini S, Frascarelli S, Brogioni S, Chiellini G, Ronca-Testoni S, Grandy DK, Scanlan TS, Cerbai E, Zucchi R. 2009. Modulation of cardiac ionic homeostasis by 3-iodothyronamine. J Cell Mol Med 13: 3082-3090.
42. Harris DR, Green WL, Craelius W. 1991. Acute thyroid hormone promotes slow inactivation of sodium current in neonatal cardiac myocytes. Biochim Biophys Acta 1045: 175-181.
43. 2+-ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation. J Clin Invest 100: 380-389.
44. Hennington BS, Zhang H, Miller MT, Granger JP, Reckelhoff JF. 1998. Angiotensin II stimulates synthesis of endothelial nitric oxide synthase. Hypertension 31: 283-288.
45. Hirata Y, Hayakawa H, Suzuki E, Kimura K, Kikuchi K, Nagano T, Hirobe M, Omata M. 1995. Direct measurement of endothelium-derived nitric oxide release by stimulation of endothelin receptors in rat kidney and its alterations in salt induced hypertension. Circulation 91: 1229-1235.
46. Hiroi Y, Kim HH, Ying H, Furuya F, Huang Z, Simoncini T, Noma K, Ueki K, Nguyen NH, Scanlan TS, Moskowitz MA, Cheng SY, Liao JK. 2006. Rapid nongenomic actions of thyroid hormone. Proc Natl Acad Sci USA 103: 14104-14109.
47. 2+ exchanger expression in rat cardiac myocytes. J Cardiovasc Pharmacol 29: 75-80.
48. Hu K, Mochly-Rosen D, Boutjdir M. 2000. Evidence for functional role of epsilon PKC isozyme in the regulation of cardiac Ca(2+) channel. Am J Physiol Heart Circ Physiol 279: H2658-H2664.
49. Huang C-J, Geller HM, Green WL, Craelius W. 1999. Acute effects of thyroid hormone analogs on sodium currents in neonatal rat myocytes. J Mol Cell Cardiol 31: 881-893.
50. Ichiki T, Usui M, Kato M, Funakoshi Y, Ito K, Egashira K, Takeshita A. 1998. Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide. Hypertension 31: 342-348.
51. Incerpi S, Luly P, De Vito P, Farias RN. 1999. Short-term effects of thyroid hormones on the Na/H antiport in L-6 myoblasts: High molecular specificity for 3, 39, 5-triiodo-L-thyronine. Endocrinology 14: 683-689.
52. Incerpi S, De Vito P, Luly P, Spagnuolo S, Leoni S. 2002. Short-term effects of thyroid hormones and 3, 5-diiodothyronine on membrane transport systems in chick embryo hepatocytes. Endocrinology 143: 1660-1668.
53. Iordanidou A, Hadzopoulou-Cladaras M, Lazou A. 2010. Non-genomic effects of thyroid hormone in adult cardiac myocytes: Relevance to gene expression and cell growth. Mol Cell Biochem 340: 291-300.
54. +)-ATPase gene expression by thyroid hormone in rat cardiocytes. Circ Res 71: 1457-1464.
55. Kavok NS, Krasilnikova OA, Babenko NA. 2001. Thyroxine signal transduction in liver cells involves phospholipase C and phospholipase D activation. Genomic independent action of thyroid hormone. BMC Cell Biol 2: 5.
56. Kenessey A, Ojamaa K. 2006. Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways. J Biol Chem 281: 20666-20672.
57. Kim D, Smith TW, Marsh JD. 1987. Effect of thyroid hormone on slow calcium channel function in cultured chick ventricular cells. J Clin Invest 80: 88-94.
58. 2+ transport and myocardial relaxation. Circ Res 75: 245-251.
59. Klein I, Ojamaa K. 2001. Thyroid hormone and the cardiovascular system. N Engl J Med 344: 501-509.
60. Kobori H, Ichihara A, Suzuki H, Miyashita Y, Hayashi M, Saruta T. 1997. Thyroid hormone stimulates renin synthesis in rats without involving the sympathetic nervous system. Am J Physiol 272: E227-E232.
61. Kobori H, Ichihara A, Miyashita Y, Hayashi M, Saruta T. 1999. Local renin-angiotensin system contributes to hyperthyroidism-induced cardiac hypertrophy. J Endocrinol 160: 43-47.
62. Köhrle J. 2000. The deiodinase family: Selenoenzymes regulating thyroid hormone availability and action. Cell Mol Life Sci 57: 1853-1863.
63. Krüger M, Sachse C, Zimmermann WH, Eschenhagen T, Klede S, Linke WA. 2008. Thyroid hormone regulates developmental titin isoform transitions via the phosphatidylinositol-3-kinase/AKT pathway. Circ Res 102: 439-447.
64. Kuzman JA, Vogelsang KA, Thomas TA, Gerdes AM. 2005. L-Thyroxine activates Akt signaling in the heart. J Mol Cell Cardiol 39: 251-258.
65. Lei J, Mariash CN, Ingbar DH. 2004. 3, 3', 5-Triiodo-L-thyronine up-regulation of Na, K-ATPase activity and cell surface expression in alveolar epithelial cells is Src kinase- and phosphoinositide 3-kinase-dependent. J Biol Chem 279: 47589-47600.
66. Lei J, Mariash CN, Bhargava M, Wattenberg EV, Ingbar DH. 2008. T3 increases Na, K-ATPase activity via a MAPK/ERK1/2-dependent pathway in rat adult alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 294: L749-L754.
67. Leonard JL, Farwell AP, Yen PM, Chin WW, Stula M. 1994. Differential expression of thyroid hormone receptor isoforms in neurons and astroglial cells. Endocrinology 135: 548-555.
68. Lin KH, Ashizawa K, Cheng SY. 1992. Phosphorylation stimulates the transcriptional activity of the human beta 1 thyroid hormone receptor. Proc Natl Acad Sci USA 89: 7737-7741.
69. Lin HY, Davis FB, Gordinier JK, Martino LJ, Davis PJ. 1999. Thyroid hormone induces activation of mitogen-activated protein kinase in cultured cells. Am J Physiol 276: C1014-C1024.
70. Lin HY, Lansing L, Merillon JM, Davis FB, Tang HY, Shih A, Vitrac X, Krisa S, Keating T, Cao HJ, Bergh J, Quackenbush S, Davis PJ. 2006. Integrin αVβ3 contains a receptor site for resveratrol. FASEB J 20: 1742-1744.
71. Lin HY, Tang HY, Shih A, Keating T, Cao G, Davis PJ, Davis FB. 2007. Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic. Steroids 72: 180-187.
72. Lin HY, Tang HY, Keating T, Wu YH, Shih A, Hammond D, Sun M, Hercbergs A, Davis FB, Davis PJ. 2008. Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: Both actions are integrin and ERK mediated. Carcinogenesis 29: 62-69.
73. Lin HY, Sun M, Lin C, Tang HY, London D, Shih A, Davis FB, Davis PJ. 2009a. Androgen-induced human breast cancer cell proliferation is mediated by discrete mechanisms in estrogen receptor-alpha-positive and -negative breast cancer cells. J Steroid Biochem Mol Biol 113: 182-188.
74. Lin HY, Sun M, Tang HY, Lin C, Luidens MK, Mousa SA, Incerpi S, Drusano GL, Davis FB, Davis PJ. 2009b. L-Thyroxine vs. 3, 5, 3-triiodo-L-thyronine and cell proliferation: Activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Am J Physiol Cell Physiol 296: C980-C991.
75. Lindemann L, Ebeling M, Kratochwil NA, Bunzow JR, Grandy DK, Hoener MC. 2005. Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors. Genomics 85: 372-385.
76. Liu Y, Redetzke RA, Said S, Pottala JV, de Escobar GM, Gerdes AM. 2008. Serum thyroid hormone levels may not accurately reflect thyroid tissue levels and cardiac function in mild hypothyroidism. Am J Physiol Heart Circ Physiol 294: H2137-H2143.
77. Marchant C, Brown L, Sernia C. 1993. Renin-angiotensin system in thyroid dysfunction in rats. J Cardiovasc Pharmacol 22: 449-455.
78. Miller LD, Park KS, Guo QM, Alkharouf NW, Malek PL, Lee NH, Liu ET, Cheng SY. 2001. Silencing of Wnt signaling and activation of multiple metabolic pathways in response to thyroid hormone-stimulated cell proliferation. Mol Cell Biol 21: 6626-6639.
79. Mitasikova M, Lin H, Soukup T, Imanaga I, Tribulova N. 2009. Diabetes and thyroid hormones affect connexin-43 and PKC-ε expression in rat heart atria. Physiol Res 58: 211-217.
80. Moreno JM, Wangensteen R, Sainz J, Rodriguez-Gomez I, Chamorro V, Osuna A, Vargas F. 2003. Role of endothelium-derived relaxing factors in the renal response to vasoactive agents in hypothyroid rats. Am J Physiol 285: E182-E188.
81. 2+-ATPase activity and share structural homologies. Proc Natl Acad Sci USA 82: 7974-7978.
82. Napoli R, Guardasole V, Angelini V, Zarra E, Terracciano D, D'Anna C, Matarazzo M, Oliviero U, Macchia V, Sacca L. 2007. Acute effects of triiodothyronine on endothelial function in human subjects. J Clin Endocrinol Metab 92: 250-254.
83. Ojamaa K, Klemperer JD, Klein I. 1996. Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 6: 505-512.
84. Oppenheimer JH, Schwartz HL, Mariash CN, Kinlaw WB, Wong NCW, Freake HC. 1987. Advances in our understanding of thyroid hormone action at the cellular level. Endocr Rev 8: 288-308.
85. Orlowski J, Lingrel JB. 1990. Thyroid and glucocorticoid hormones regulate the expression of multiple Na, K-ATPase genes in cultured neonatal rat cardiac myocytes. J Biol Chem 265: 3462-3470.
86. Pantos C, Paizis I, Mourouzis I, Moraitis P, Tzeis S, Karamanoli E, Mourouzis C, Karageorgiou H, Cokkinos DV. 2005. Blockade of angiotensin II type 1 receptor diminishes cardiac hypertrophy, but does not abolish thyroxin-induced preconditioning. Horm Metab Res 37: 500-504.
87. Pantos C, Xinaris C, Mourouzis I, Malliopoulou V, Kardami E, Cokkinos DV. 2007a. Thyroid hormone changes cardiomyocyte shape and geometry via ERK signaling pathway: Potential therapeutic implications in reversing cardiac remodeling? Mol Cell Biochem 297: 65-72.
88. Pantos C, Mourouzis I, Markakis K, Dimopoulos A, Xinaris C, Kokkinos AD, Panagiotou M, Cokkinos DV. 2007b. Thyroid hormone attenuates cardiac remodeling and improves hemodynamics early after acute myocardial infarction in rats. Eur J Cardiothorac Surg 32: 333-339.
89. Park KW, Dai HB, Ojamaa K, Lowenstein E, Klein I, Sellke FW. 1997. The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries. Anesth Analg 85: 734-738.
90. +-dependent phosphatase in rat heart. Am J Physiol 232: C196-C201.
91. Piehl S, Heberer T, Balizs G, Scanlan TS, Smits R, Koksch B, Kohrle J. 2008. Thyronamines are isozyme-specific substrates of deiodinases. Endocrinology 149: 3037-3045.
92. Pizzagalli F, Hagenbuch B, Stieger B, Klenk U, Folkers G, Meier PJ. 2002. Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter. Mol Endocrinol 16: 2283-2296.
93. Quesada A, Sainz J, Wangensteen R, Rodriguez-Gomez I, Vargas F, Osuna A. 2002. Nitric oxide synthase activity in hyperthyroid and hypothyroid rats. Eur J Endocrinol 147: 117-122.
94. Rodriguez-Gomez I, Sainz J, Wangensteen R, Moreno JM, Duarte J, Osuna A, Vargas F. 2003. Increased pressor sensitivity to chronic nitric oxide deficiency in hyperthyroid rats. Hypertension 42: 220-225.
95. Rosenfeld MG, Glass CK. 2001. Coregulator codes of transcriptional regulation by nuclear receptors. J Biol Chem 276: 36865-36868.
96. 2+-ATPase activity: Stimulation in vitro by thyroid hormone. Arch Biochem Biophys 229: 379-385.
97. Sabatino L, Chopra IJ, Tanavoli S, Iacconi P, Iervasi G. 2001. A radioimmunoassay for type I iodothyronine 5'-monodeiodinase in human tissues. Thyroid 11: 733-739.
98. Sabatino L, Colantuoni A, Iervasi G. 2005. Is the vascular system a main target for thyroid hormones? From molecular and biochemical findings to clinical perspectives. Curr Vasc Pharmacol 3: 133-145.
99. 2+ signaling by ligand stimulated thyroid hormone receptor. J Cell Biol 167: 915-924.
100. Sakaguchi Y, Cui G, Sen L. 1996. Acute effects of thyroid hormone on inward rectifier potassium channel currents in guinea pig ventricular myocytes. Endocrinology 137: 4744-4751.
101. Sanford CF, Griffin EE, Wildenthal K. 1978. Synthesis and degradation of myocardial protein during the development and regression of thyroxine-induced cardiac hypertrophy in rats. Circ Res 43: 688-694.
102. Scanlan TS, Suchland KL, Hart ME, Chiellini G, Huang Y, Kruzich PJ, Frascarelli S, Crossley DA, Bunzow JR, Ronca-Testoni S, Lin ET, Hatton D, Zucchi R, Grandy DK. 2004. 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat Med 10: 638-642.
103. Schmidt BM, Martin N, Georgens AC, Tillmann HC, Feuring M, Christ M, Wehling M. 2002. Nongenomic cardiovascular effects of triiodothyronine in euthyroid male volunteers. J Clin Endocrinol Metab 87: 1681-1686.
104. + channel activation in ventricular myocytes. Am J Physiol Heart Circ Physiol 283: H2119-H2129.
105. Shenoy R, Klein I, Ojamaa K. 2001. Differential regulation of SR calcium transporters by thyroid hormone in rat atria and ventricles. Am J Physiol 281: H1690-H1696.
106. Shih A, Lin HY, Davis FB, Davis PJ. 2001. Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase. Biochemistry 40: 2870-2878.
107. Shimoni Y. 1999. Hormonal control of cardiac ion channels and transporters. Prog Biophys Mol Biol 72: 67-108.
108. Shupnik MA, Ridgway EC. 1987. Thyroid hormone control of thyrotropin gene expression in rat anterior pituitary cells. Endocrinology 121: 619-624.
109. Singh G, Thompson EB, Gulati A. 1994. Altered endothelin 1 concentration in the brain and peripheral regions during thyroid dysfunction. Pharmacology 49: 184-191.
110. Storey NM, O'Bryan JP, Armstrong DL. 2002. Rac and Rho mediate opposing hormonal regulation of the ether-a-go-go related potassium channel. Curr Biol 12: 27-33.
111. Storey NM, Gentile S, Ullah H, Russo A, Muessel M, Erxleben C, Armstrong DL. 2006. Rapid signaling at the plasma membrane by a nuclear receptor for thyroid hormone. Proc Natl Acad Sci USA 103: 5197-5201.
112. Su L, Dai Y, Deng W, Yin YH. 2008. Renin-angiotensin system blocking agents reverse the myocardial hypertrophy in experimental hyperthyroid cardiomyopathy via altering intracellular calcium handling. Zhonghua Xin Xue Guan Bing Za Zhi 36: 744-749.
113. Sun ZQ, Ojamaa K, Coetzee WA, Artman M, Klein I. 2000. Effects of thyroid hormone on action potential and repolarizing currents in rat ventricular myocytes. Am J Physiol 278: E302-E307.
114. Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, Salvetti A, Ferrannini E, Monzani F. 2003. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: Beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 88: 3731-3737.
115. Trivieri MG, Oudit GY, Sah R, Kerfant BG, Sun H, Gramolini AO, Pan Y, Wickenden AD, Croteau W, Morreale de Escobar G, Pekhletski R, St Germain D, Maclennan DH, Backx PH. 2006. Cardiac-specific elevations in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction. Proc Natl Acad Sci USA 103: 6043-6048.
116. Tse J, Wrenn RW, Kuo JF. 1980. Thyroxine-induced changes in characteristics and activities of beta-adrenergic receptors and adenosine 3', 5'-monophosphate and guanosine 3', 5'-monophosphate systems in the heart may be related to reputed catecholamine supersensitivity in hyperthyroidism. Endocrinology 107: 6-16.
117. Tzagarakis-Foster C, Privalsky ML. 1998. Phosphorylation of thyroid hormone receptors by protein kinase A regulates DNA recognition by specific inhibition of receptor monomer binding. J Biol Chem 273: 10926-10932.
118. Vargas F, Fernández-Rivas A, García-Estañ J, García del Rio C. 1995. Endothelium-dependent and endothelium-independent vasodilation in hyperthyroid and hypothyroid rats. Pharmacology 51: 308-314.
119. Vassy R, Nicholas P, Yin YL, Perret GY. 1997. Nongenomic effect of triiodothyronine on cell surface b-adrenoceptors in cultured embryonic cardiac myocytes. Proc Soc Exp Biol Med 214: 352-358.
120. 2+ in cat atrial myocytes. J Physiol 546: 491-499.
121. Watanabe H, Washizuka T, Komura S, Yoshida T, Hosaka Y, Hatada K, Aizawa Y, Chinushi M, Yamamoto T, Ma M, Watanabe K. 2005. Genomic and nongenomic regulation of L-type calcium channels in rat ventricle by thyroid hormone. Endocr Res 31: 59-70.
122. Williams LT, Lefkowitz RJ, Watanabe AM, Hathaway DR, Besch HR, Jr. 1977. Thyroid hormone regulation of beta-adrenergic receptor number. J Biol Chem 252: 2787-2789.
123. Xiao Z, Zhang Z, Diamond SL. 1997. Shear stress induction of the endothelial nitric oxide synthase gene is calcium dependent but not calcium-activated. J Cell Physiol 171: 205-211.
124. Yoneda K, Takasu N, Higa S, Oshiro C, Oshiro Y, Shimabukuro M, Asahi T. 1998. Direct effects of thyroid hormones on rat coronary artery: Nongenomic effects of triiodothyronine and thyroxine. Thyroid 8: 609-613.
125. Zinman T, Shneyvays V, Tribulova N, Manoach M, Shainberg A. 2006. Acute, nongenomic effect of thyroid hormones in preventing calcium overload in newborn rat cardiocytes. J Cell Physiol 207: 220-231.
126. Zucchi R, Chiellini G, Scanlan TS, Grandy DK. 2006. Trace amine-associated receptors and their ligands. Br J Pharmacol 149: 967-978.